You have read all your free articles, to continue reading subscribe to read the rest of this content.
Karolinska Development AB has sold its shares in Axelar AB to The Foundation for Baltic and East European Studies (Östersjöstiftelsen). The agreement is in keeping with Karolinska Development's current strategy. “Karolinska Development’s new strategy includes focusing on our strategicAlready a subscriber Login You have read all your free articles,…
Lobsor Pharmaceuticals has announced that Lecigon has been approved, and that the Swedish Medical Products Agency (MPA) has confirmed End of Procedure according to the European Mutual Recognition Procedure (MRP) including Denmark, Finland and Norway. "We are delighted to have now received confirmAlready a subscriber Login You have read all…
The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on effiAlready a subscriber Login You have read all your free articles, to continue…
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a 2.0 mg dose of Ozempic (once-weekly semaglutide subcutaneous injection), a glucagon-like peptide-1 (GLP-1) analogue for the treatment of adults with type 2 diabetes. Ozempic is now approved in the US at 0.5 mAlready a subscriber…
